Resultados de procura - David E. Heppner
- Mostrando 1 - 20 Resultados de 27
- Go to Next Page
-
1
Lazertinib: Breaking the mold of third-generation EGFR inhibitors por Kishan B. Patel, David E. Heppner
Publicado 2025Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors por Kristopher W. Hoyt, Daniel A. Urul, Blessing C. Ogboo, Florian Wittlinger, Stefan Laufer, Erik Schaefer, Earl W. May, David E. Heppner
Publicado 2023Artigo -
13
DUOX1 silencing in lung cancer promotes EMT, cancer stem cell characteristics and invasive properties por Andrew C. Little, Derek Sham, Milena Hristova, Karamatullah Danyal, David E. Heppner, R Bauer, Lynn Sipsey, Aida Habibovic, Albert van der Vliet
Publicado 2016Artigo -
14
-
15
Cysteine perthiosulfenic acid (Cys-SSOH): A novel intermediate in thiol-based redox signaling? por David E. Heppner, Milena Hristova, Tomoaki Ida, Ana Mijušković, Christopher M. Dustin, Virág Bogdándi, Jon M. Fukuto, Tobias P. Dick, Péter Nagy, Jianing Li, Takaaki Akaike, Albert van der Vliet
Publicado 2017Artigo -
16
Direct cysteine sulfenylation drives activation of the Src kinase por David E. Heppner, Christopher M. Dustin, Chenyi Liao, Milena Hristova, Carmen Veith, Andrew C. Little, Bethany A. Ahlers, Sheryl L. White, Bin Deng, Ying‐Wai Lam, Jianing Li, Albert van der Vliet
Publicado 2018Artigo -
17
Lung epithelial protein disulfide isomerase A3 (PDIA3) plays an important role in influenza infection, inflammation, and airway mechanics por Nicolas Chamberlain, Bethany R. Korwin-Mihavics, Emily M. Nakada, S. Bruno, David E. Heppner, David G. Chapman, Sidra M. Hoffman, Albert van der Vliet, Benjamin T. Suratt, Oliver Dienz, John F. Alcorn, Vikas Anathy
Publicado 2019Artigo -
18
Molecular basis for cooperative binding and synergy of ATP-site and allosteric EGFR inhibitors por Tyler S. Beyett, Ciric To, David E. Heppner, Jaimin K. Rana, Anna M. Schmoker, Jaebong Jang, Dries J.H. De Clercq, Gabriel Gómez, David A. Scott, Nathanael S. Gray, Pasi A. Jänne, Michael J. Eck
Publicado 2022Artigo -
19
DUOX1 mediates persistent epithelial EGFR activation, mucous cell metaplasia, and airway remodeling during allergic asthma por Aida Habibovic, Milena Hristova, David E. Heppner, Karamatullah Danyal, Jennifer L. Ather, Yvonne Janssen‐Heininger, Charles G. Irvin, Matthew E. Poynter, Lennart K. A. Lundblad, Anne E. Dixon, Miklós Geiszt, Albert van der Vliet
Publicado 2016Artigo -
20
Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors por Dries J.H. De Clercq, David E. Heppner, Ciric To, Jaebong Jang, Eunyoung Park, Cai‐Hong Yun, Mierzhati Mushajiang, Bo Hee Shin, Thomas W. Gero, David A. Scott, Pasi A. Jänne, Michael J. Eck, Nathanael S. Gray
Publicado 2019Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Biochemistry
Chemistry
Epidermal growth factor receptor
Receptor
Enzyme
Gene
Cancer research
Cell biology
EGFR inhibitors
Organic chemistry
Cancer
Mutant
Allosteric regulation
Gefitinib
Genetics
Medicine
T790M
Tyrosine kinase
Computational biology
Erlotinib
Internal medicine
Kinase
Reactive oxygen species
Signal transduction
Stereochemistry
Biophysics
Combinatorial chemistry
Cysteine
NADPH oxidase